Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 2021 Discussion: The ISCHEMIA Trial
Author(s): Gregg Stone , Harriette Van Spall Added: 2 years ago
Dr Gregg W Stone (Mount Sinai Heart Health System, New York, US) and Dr Harriette Van Spall (McMaster University, Hamilton, CA) discuss the latest results from the ISCHEMIA trial. The trial assessed the impact of completeness of revascularization on clinical outcomes in patients with stable ischemic heart disease treated with an invasive versus conservative strategy. Recorded remotely from New… View more

Anticoagulation

Vascular Disease and Surgery
ISCHEMIA Trial: Key Questions and Answers
Author(s): José López-Sendón , Raul Moreno , Juan Tamargo Added: 2 years ago

Prevention & Chronic Conditions
The ISCHEMIA Trial: Editorial
Author(s): Pablo Avanzas , Juan Carlos Kaski Added: 3 years ago

MI/ACS
The ISCHEMIA Trial: What is the Message for the Interventionalist?
Author(s): Emmanuel Ako , Sukhjinder Nijjer , Abtehale Al-Hussaini , et al Added: 2 years ago

Prevention & Chronic Conditions

Intervention
What is the Real Message of the ISCHEMIA Trial from a Clinician’s Perspective?
Author(s): Islam Y Elgendy , Carl J Pepine Added: 3 years ago
Management goals in patients with stable coronary disease or chronic coronary syndrome include controlling symptoms and reducing the risk of future cardiovascular events.1,2 Randomised trials conducted in the bare metal stents era have indicated that an invasive management strategy, which includes coronary angiography, followed by percutaneous or surgical revascularisation, if indicated, was not… View more

Prevention & Chronic Conditions
03/03/2021
Author(s): Jonathan Jiunn Liang Yap , Derek P Chew , Gregg Stone , et al Added: 3 years ago

Anticoagulation

Vascular Disease and Surgery
The Core Message of ISCHEMIA
Author(s): Kreton Mavromatis , William E Boden Added: 3 years ago
Defining the best management strategies for patients with stable ischaemic heart disease (SIHD) has been the subject of scientific study for nearly 50 years since the advent of coronary artery bypass grafting (CABG) surgery by Favaloro in 1967 and, a decade later, the development of percutaneous coronary intervention (PCI) by Gruentzig in 1977.1,2 Randomised controlled trials of CABG surgery… View more

Prevention & Chronic Conditions
Research Area(s) / Expertise: Job title: Professor of Medicine
Dr. William E. Boden is Professor of Medicine at Boston University School of Medicine and Lecturer in Medicine, Harvard Medical School, in Boston, Massachusetts. In July 2016, Dr. Boden returned to the VA Boston Healthcare System to assume new duties as the Physician Research Lead for the New England VA Healthcare System and as the Scientific Director of the Clinical Trials Network, which is… View more
Johnathan Yap
Research Area(s) / Expertise:

Coronary Interventions

Coronary Physiology

 Job title: Consultant Cardiologist
Clinical Associate Professor Jonathan Yap is a Consultant with the Department of Cardiology at NHCS. His subspeciality interest is in interventional cardiology, pulmonary hypertension and structural heart disease including transcatheter aortic valve interventions (TAVI) for aortic stenosis. He spent a year in the United States performing his advanced fellowship in structural heart interventions… View more
Coronary Microvascular Spasm
Author(s): Shigeo Godo , Jun Takahashi , Takashi Shiroto , et al Added: 1 year ago

Intervention